ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 153 filers reported holding ITEOS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,116,900 | -85.8% | 102,000 | -82.9% | 0.17% | -84.3% |
Q2 2023 | $7,891,040 | -2.7% | 596,000 | 0.0% | 1.10% | -5.9% |
Q1 2023 | $8,111,560 | -6.7% | 596,000 | +33.9% | 1.17% | -13.7% |
Q4 2022 | $8,690,850 | -40.1% | 445,000 | -1.3% | 1.35% | -56.9% |
Q1 2022 | $14,506,000 | -30.9% | 450,776 | 0.0% | 3.14% | -23.2% |
Q4 2021 | $20,988,000 | – | 450,776 | – | 4.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |